Dosing in Non-Valvular AF

Dabigatran (high dose)

150 mg twice daily

Contraindicated if CrCl < 30 mL/hr

Dabigatran (low dose)

110 mg twice daily

Contraindicated if CrCl < 30 mL/hr

Rivaroxaban

20 mg daily if CrCl ≥50 mL/hr

15 mg daily if CrCl 30 – 50 mL/hr

Contraindicated if CrCl < 30 mL/hr

Apixaban

5 mg twice daily

2.5 mg twice daily if at least 2 of the 3:

- Age ≥80 years

- Weight < 60 kg

- Creatinine

Contraindicated if CrCl < 25 mL/hr

Edoxaban (high dose)

60 mg daily

30 mg daily if at least 1 of the 3:

CrCl 30 – 50 mL/hr

Weight < 60 kg

Concomitant P-glycoprotein inhibitor or dronedarone use

Contraindicated if CrCl < 30 mL/hr

Edoxaban (low dose)

30 mg daily

15 mg daily if at least 1 of the 3:

CrCl 30- 50 mL/hr

Weight < 60 kg

Concomitant P-glycoprotein inhibitor or dronedarone use

Contraindicated if CrCl < 30 mL/hr

Table 7: NOAC Dosing Regimens in Patients with Non-Valvular AF